Table 3.
Factors associated with sensitization in non-Black participants.
| Variable | SPT | FS | AS | ||||||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| No (N=67) | Yes (N=59) | p | No (N=83) | Yes (N=43) | p | No (N=84) | Yes (N=42) | P | |
| Median age, years (IQR) | 1.9 (1.6, 2.3) | 2.1 (1.6, 2.5) | 0.095 | 2.1 (1.6, 2.4) | 2.0 (1.5, 2.5) | 0.79 | 1.9 (1.5, 2.3) | 2.4 (1.8, 2.5) | 0.008 |
| Male (%) | 49 | 61 | 0.25 | 52 | 60 | 0.46 | 51 | 62 | 0.34 |
| Public insurance (%) | 33 | 21 | 0.17 | 31 | 21 | 0.33 | 28 | 27 | 0.91 |
| Season of study visit | 0.45 | 0.99 | 0.24 | ||||||
| Winter (%) | 28 | 19 | 24 | 23 | 27 | 17 | |||
| Spring (%) | 30 | 32 | 31 | 30 | 32 | 29 | |||
| Summer (%) | 13 | 22 | 17 | 19 | 13 | 26 | |||
| Fall (%) | 28 | 27 | 28 | 28 | 27 | 29 | |||
| Vitamin D supplementation (%) | 27 | 20 | 0.52 | 24 | 23 | 0.91 | 30 | 12 | 0.046 |
| Low 25(OH)D (%) | 14.9 | 25.4 | 0.21 | 16.9 | 25.6 | 0.35 | 17.9 | 23.8 | 0.58 |
| Median SCORAD ((IQR) | 18.7 (10.1, 24.8) | 24.9 (13.1, 36.3) | 0.006 | 18.7 (10.1, 25.0) | 26.4 (15.0, 38.6) | <0.001 | 18.6 (11.0, 25.2) | 27.5 (13.6, 39.7) | 0.003 |
| GM of FLG expression (GCI) | 9.3x10−4 (5.7x10−4 …0.0015) | 6.7x10−4 (4.3x10−4 …0.0010) | 0.31 | 9.3x10−4 (6.0x10−4 …0.0014) | 6.0x10−4 (3.6x10−4 …9.8x10−4) | 0.18 | 9.0x10−4 (5.9x10−4 …0.0014−4) | 6.2x10−4 (3.6x10−4 …0.0011) | 0.27 |
| Median non-lesional TEWL ((IQR) | 10.0 (7.3, 13.9) | 10.8 (7.5, 15.5) | 0.76 | 10.2 (7.3, 14.4) | 10.8 (7.5, 15.5) | 0.75 | 10.0 (7.5, 13.8) | 11.1 (7.0, 16.7) | 0.86 |
GM: geographic mean. GCI: geometric confidence interval.